Gufic BioSciences Q4 Results
- BSE: 509079
- NSE: GUFICBIO
- ISIN: INE742B01025
- Sector: Biotechnology & Drugs
BSE
284.60
-3.00 (-1.04%)
-3.00 (-1.04%)Volume803.00
Updated: Fri 15 May, 2026 | 15:28:58
NSE
283.25-3.25 (-1.13%)
-3.25 (-1.13%)Volume44.95 K
Updated: Fri 15 May, 2026 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Gufic BioSciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 185.08 | 206.12 | 3.69% | 165.11 | 12.10% |
| Depreciation/ Amortization | 7.84 | 7.69 | 69.84% | 4.34 | 80.64% |
| Operating Income | 19.94 | 25.29 | -31.97% | 29.89 | -33.29% |
| Net Income | 7.72 | 12.42 | -60.01% | 20.05 | -61.49% |
| Other Operating Expenses Total | 51.86 | 57.32 | 13.37% | 42.55 | 21.89% |
| Net Income Before Taxes | 10.53 | 17.72 | -59.92% | 27.12 | -61.19% |
| Total Revenue | 205.02 | 231.41 | -1.33% | 194.99 | 5.14% |
| Selling/ General/ Admin Expenses Total | 35.71 | 40.09 | 5.16% | 29.60 | 20.63% |
| Diluted Normalized EPS | 0.77 | 1.24 | -60.19% | 2.00 | -61.54% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.